You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

OXALIPLATIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Oxaliplatin patents expire, and when can generic versions of Oxaliplatin launch?

Oxaliplatin is a drug marketed by Accord Hlthcare, Actavis, Actavis Totowa, Am Regent, Chartwell Molecular, Eugia Pharma, Fresenius Kabi Oncol, Fresenius Kabi Usa, Gland, Gland Pharma Ltd, Hengrui Pharma, Hospira Inc, Hospira Worldwide, Kindos, Mylan Labs Ltd, Novast Labs, Qilu Pharm Hainan, Sandoz, Sun Pharm, and Teva Pharms. and is included in twenty-seven NDAs.

The generic ingredient in OXALIPLATIN is oxaliplatin. There are twenty-six drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the oxaliplatin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Oxaliplatin

A generic version of OXALIPLATIN was approved as oxaliplatin by HOSPIRA WORLDWIDE on August 7th, 2009.

  Try a Trial

Drug patent expirations by year for OXALIPLATIN
Drug Prices for OXALIPLATIN

See drug prices for OXALIPLATIN

Recent Clinical Trials for OXALIPLATIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Grünenthal GmbHPhase 3
Institut Cancerologie de l'OuestPhase 3
Mansoura UniversityPhase 1/Phase 2

See all OXALIPLATIN clinical trials

Pharmacology for OXALIPLATIN
Paragraph IV (Patent) Challenges for OXALIPLATIN
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
ELOXATIN Injection oxaliplatin 5 mg/mL, 40 mL vials 021759 1 2007-07-16
ELOXATIN Injection oxaliplatin 5 mg/mL, 10 mL and 20 mL vials 021759 11 2007-02-09

US Patents and Regulatory Information for OXALIPLATIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novast Labs OXALIPLATIN oxaliplatin INJECTABLE;INTRAVENOUS 207562-001 Oct 16, 2018 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Hospira Worldwide OXALIPLATIN oxaliplatin INJECTABLE;INTRAVENOUS 078813-001 Aug 7, 2009 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Sandoz OXALIPLATIN oxaliplatin INJECTABLE;INTRAVENOUS 078817-001 Jan 24, 2011 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Teva Pharms OXALIPLATIN oxaliplatin INJECTABLE;INTRAVENOUS 022160-002 Aug 7, 2009 AP RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Qilu Pharm Hainan OXALIPLATIN oxaliplatin INJECTABLE;INTRAVENOUS 204368-002 Jun 7, 2016 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Sandoz OXALIPLATIN oxaliplatin INJECTABLE;INTRAVENOUS 090849-001 Apr 28, 2011 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Sun Pharm OXALIPLATIN oxaliplatin INJECTABLE;INTRAVENOUS 202922-001 Apr 8, 2014 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.